# Lexeo Therapeutics, Inc.: Form 8-K, filed Jun 28, 2024

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2024-06-28
- Accepted by EDGAR: Jun 28, 2024, 07:33 ET
- Period: 2024-06-28
- Accession: 0000950170-24-078774
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/lxeo-20240628.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/lxeo-20240628.htm

Filed Jun 28, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-078774. Last ingested by Listed: Oct 29, 2026, 07:31 ET. No prices; not investment advice.